Business
What’s The Difference Between Delta-9 And Delta-10 THC?
The difference between the chemical structure of delta-9 and delta-10 THC gives rise to different chemical effects in the body.
In the cannabis industry, knowledge is important if one is to get the best out of the products available. It’s even more important to ensure that accurate information is what you have in your hand so as to avoid unwanted misinformation.
One of the areas of cannabis that has been confusing to many recently is delta-10 THC. Many often hear “THC” and believe that anything that includes the cannabinoid results in a psychoactive effect. This is true in many ways, and untrue in some.
What Is Delta-10 THC?
Most of us are probably familiar with basic chemistry, so we will start from there to explain what delta-10 THC is. Delta-10 THC is a structural isomer of delta-9 THC, which produces psychoactive effects in the human body. Though psychoactive, delta-10 gives rise to a different type of feel compared to delta-9 THC. Delta-10 occurs in trace amounts in the cannabis plant, which makes it very hard to get substantial quantities of the product available for use. The chemical difference between both compounds is the carbon-carbon double bond, located at carbon-10 in delta-10 THC, and carbon-9 in delta-9 THC.
What we call THC in the cannabis plant largely refers to delta-9 THC, as it was the first psychoactive compound extracted from the cannabis plant. The origin and discovery of delta-10 THC can be classified as serendipitous because it occurred after a fire incident in California that resulted in a batch of hemp unwittingly contaminated with a fire-retardant. After processing, it was discovered that a strange crystal formation had appeared in the extract which was later identified as delta-10 THC. Further testing showed this newly identified compound has similar psychoactive effects with delta-9 THC, but some degree of different pharmacological effect.
Delta-10 THC comes in different ranges of products in the market which is similar to its delta 9 counterparts. Varieties of products available include disposable pens, vape cartridges, gummies, tinctures, and flower and pre-rolls with delta-10 THC sprayed on it.
Differences Between Delta-9 and Delta-10 THC
As stated earlier, the difference between the chemical structure of delta-9 and delta-10 THC gives rise to different chemical effects in the body. When compared side-by-side, it is easy to see the uniqueness of delta-10 THC, and why it is possible for it to be the next big thing in the cannabis industry.
Effects
Delta-10 THC is known for its high-octane and energetic feel. It is a mood enhancer that’s proven to improve cognitive ability and also give rise to a special stimulating euphoric feeling. Delta-9 THC, on the other hand, has a special sedative and relaxing effect culminated with euphoria at high doses.
The effect of delta-9 varies in different people as some people experience relaxing and sedative effects when delta-9 is used in medium doses. Therefore, larger doses of delta-9 will be required to give the expected stimulating and energetic feel. Delta-10 THC has more stimulating effects than sedatives which means it is prone to stimulating effects in small and medium doses compared to delta-9 THC which needs larger doses.
Legality
The legal stance of delta-9 THC is common knowledge at this stage with the FDA still classifying the natural product as illegal. However, a good number of states have legalized the use of delta-9 for medical and recreational use. Delta-10 THC has less restriction, especially because it can be derived from hemp. The natural compound is presently legal federally and in 38 states in the US. This is largely due to its less dramatic high and lower potency.
Availability
The market availability of both compounds is quite different as expected especially given the different legal status of both compounds federally. Delta-10 THC is more available given its reduced federal restriction which means it can be easily ordered online anywhere in the legal states. Availability of delta-9 THC is more limited given its legal status. It is also to purchase delta 9 THC in states where it is legal especially states where local governments have regulations limiting who legally produces and sells delta-9.
Cost
On average, the difference between the cost of both products is entirely enormous. Delta-9 THC is regarded as cheap with the average cost ranging from $0.02 to $0.08 per mg. Meanwhile, delta-10 THC is regarded as moderate in terms of cost with one mg ranging from $0.07 to $0.12. These variations in prices are not exactly static everywhere as situations around each market can affect prices.
Dose
The standard dose for beginners with delta-10 THC is 5 to 10 mg, while the standard dose for delta-9 THC for beginners is 2.5 to 5mg. It is important to state that the best way to go with these products is to use trial runs to establish the right dose that will give you your required effect. Getting your product from the right source is also important if you are to get the intended dose of the product.
Bottom Line
Considering the uniqueness of delta-10 THC, it is easy to see its market appeal and why it could just be the next big thing in the cannabis industry. On your way to enjoying the recreational effects of delta-10, it’s important to always factor in the purity of the product being purchased and used as well as evidence of third-party testing. This helps to ensure the product being used is not contaminated and protects the user from unwanted deleterious effects.
Source: https://thefreshtoast.com/cannabis/whats-the-difference-between-delta-9-thc-and-delta-10-thc/
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Marijuana companies suing US attorney general in federal prohibition challenge
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business1 year agoCan Cannabis Help Seasonal Depression
-
Blogs1 year agoCannabis Art Is Flourishing On Etsy